Series A - Farber Xintian
Investment Firm
Overview
Farber Xintian CRO company engaged in clinical services of radionuclide drugs.
Announced Date
May 11, 2024
Funding Type
Series A
Highlights
N/A
Location
N/A
Social
N/A
Investor Lead
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
Farber Xintian raised $13837575 on 2024-05-11 in Series A
Farber Xintian CRO company engaged in clinical services of radionuclide drugs.
Company Funding History
2
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jan 19, 2022 |  Seed Round - Farber Xintian | 4 | - | 15.8M |
| May 11, 2024 | Series A - Farber Xintian | 2 | - | 13.8M |
Recent Activity
There is no recent news or activity for this profile.